“…Various alternatives to FACS and MACS for cellular therapies, such as mRBC production, have been proposed and were recently reviewed (Masri, Hoeve, Sousa, & Willoughby, 2017). Recent work on deterministic lateral displacement (Campos‐Gonzalez et al, 2018) and inertial vortexes (Pritchard et al, 2019) have demonstrated application to CAR‐T cell processing and inertial focussing has been used to isolate, enrich, and purify stem cells (Hur, Brinckerhoff, Walthers, Dunn, & Di Carlo, 2012; Lee et al, 2018; Song et al, 2017), to obtain desired subpopulation (Lee et al, 2011, 2014; Poon et al, 2015), to isolate single cells from clusters (Nathamgari et al, 2015), for nonviable cell removal (Kwon, Yao, Hamel, & Han, 2018) as well as microcarrier scaffold removal (Moloudi et al, 2018).…”